New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
08:47 EDTPRGOPerrigo launches generic version of Neptazane tablets
Perrigo has launched methazolamide tablets, the generic equivalent to Neptazane tablets. This product is a component of the contingent rights Perrigo received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals last June. Methazolamide tablets are indicated for the treatment of several ocular conditions. Estimated annual sales are approximately $12M.
News For PRGO From The Last 14 Days
Check below for free stories on PRGO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
08:15 EDTPRGOPerrigo files patent challenge for generic version of Taro's Topicort
Subscribe for More Information
July 24, 2014
12:56 EDTPRGOPerrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0%
Subscribe for More Information
July 23, 2014
10:02 EDTPRGOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTPRGODeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTPRGOPerrigo initiated with a Buy at Deutsche Bank
Target $189.
July 18, 2014
09:35 EDTPRGOPerrigo would rather make acquisitions than be sold, dealReporter says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use